Pyridoxamine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePyridoxamine
Drug Alias NamePyridoxamine dihydrochloride吡哆胺PyridoxylaminePyridorinK-163 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycation end product inhibitors
TargetsAdvanced glycation end product
Therapy Area/IndicationsKidney CalculiDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPoland +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiostratum Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNephrogenex IncBiostratum AbThe University Of Kansas Medical Center
Active IndicationsN/A
Inactive IndicationsKidney CalculiDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG